| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article; Multicenter Study
- Language: English
- [Clin Rheumatol] 2021 Nov; Vol. 40 (11), pp. 4589-4596. <i>Date of Electronic Publication: </i>2021 Jun 17.
- MeSH Terms: Scleroderma, Systemic* / complications ; Scleroderma, Systemic* / epidemiology ; Ventricular Dysfunction, Left* / diagnostic imaging ; Ventricular Dysfunction, Left* / epidemiology ; China / epidemiology ; Cohort Studies ; Humans ; Prevalence ; Prospective Studies ; Risk Factors
- References: Hughes M, Herrick AL (2019) Systemic sclerosis. Br J Hosp Med (Lond) 80:530–536. https://doi.org/10.12968/hmed.2019.80.9.530. ; Zhong L, Pope M, Shen Y, Hernandez JJ, Wu L (2019) Prevalence and incidence of systemic sclerosis: A systematic review and meta-analysis. Int J Rheum Dis 22:2096–2107. https://doi.org/10.1111/1756-185X.13716. ; Allanore Y, Meune C (2010) Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin. Clin Exp Rheumatol 28:S48–53. ; Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM (1976) Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 53:483–490. https://doi.org/10.1161/01.cir.53.3.483. ; Wangkaew S, Prasertwitayakij N, Phrommintikul A, Puntana S, Euathrongchit J (2017) Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study. Rheumatol Int 37:2087–2094. https://doi.org/10.1007/s00296-017-3846-7. ; Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F, Giuggioli D, Cuomo G, Rosada M, Bombardieri S, Todesco S, Tirri G; Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc) (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81:139–153. https://doi.org/10.1097/00005792-200203000-00004. ; Aguglia G, Sgreccia A, Bernardo ML, Carmenini E, Giusti De Marle M, Reali A, Morelli S (2001) Left ventricular diastolic function in systemic sclerosis. J Rheumatol 28:1563–1567. ; Faludi R, Költő G, Bartos B, Csima G, Czirják L, Komócsi A (2014) Five-year follow-up of left ventricular diastolic function in systemic sclerosis patients: determinants of mortality and disease progression. Semin Arthritis Rheum 44:220–227. https://doi.org/10.1016/j.semarthrit.2014.04.001. ; Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, Varga J (2015) Systemic sclerosis. Nat Rev Dis Primers 23:15002. https://doi.org/10.1038/nrdp.2015.2. ; Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119. https://doi.org/10.1093/eurheartj/ehv317. ; Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193. https://doi.org/10.1093/ejechocard/jep007. ; Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Alexandru Popescu B, Waggoner AD; Houston, Texas; Oslo, Norway; Phoenix, Arizona; Nashville, Tennessee; Hamilton, Ontario, Canada; Uppsala, Sweden; Ghent and Liège, Belgium; Cleveland, Ohio; Novara, Italy; Rochester, Minnesota; Bucharest, Romania; and St. Louis, Missouri (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17:1321–1360. https://doi.org/10.1093/ehjci/jew082. ; Heine JJVAFPAUPUFKM (1926) Über ein eigenartiges Krankheitsbild von diffuser Skelerosis der Haut und innerer Organe. Virchows Arch Pathol Anat Physiol Klin Med 262:351–382. ; Fernández-Codina A, Simeón-Aznar CP, Pinal-Fernandez I, Rodríguez-Palomares J, Pizzi MN, Hidalgo CE, Guillén-Del Castillo A, Prado-Galbarro FJ, Sarria-Santamera A, Fonollosa-Plà V, Vilardell-Tarrés M (2017) Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int 37:75–84. https://doi.org/10.1007/s00296-015-3382-2. ; Vemulapalli S, Cohen L, Hsu V (2016) Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort. Scand J Rheumatol 46:281–287. https://doi.org/10.1080/03009742.2016.1206963. ; Akdogan A, Kaya EB, Sahin A, Okutucu S, Yakut E, Kalyoncu U, Aksoy H, Karadag O, Calguneri M, Tokgozoglu L, Kiraz S, Ertenli I (2011) Relationship between left ventricular diastolic dysfunction and six minute walk test in patients with systemic sclerosis. Int J Rheum Dis 14:379–383. https://doi.org/10.1111/j.1756-185X.2011.01672.x. ; Hinchcliff M, Desai CS, Varga J, Shah SJ (2012) Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol 30:S30–37. ; Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, Döring A, Broeckel U, Riegger G, Schunkert H (2003) Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 24:320–328. https://doi.org/10.1016/s0195-668x(02)00428-1. ; Kloch-Badelek M, Kuznetsova T, Sakiewicz W, Tikhonoff V, Ryabikov A, González A, López B, Thijs L, Jin Y, Malyutina S, Stolarz-Skrzypek K, Casiglia E, Díez J, Narkiewicz K, Kawecka-Jaszcz K, Staessen JA; European Project On Genes in Hypertension (EPOGH) Investigators (2012) Prevalence of left ventricular diastolic dysfunction in European populations based on cross-validated diagnostic thresholds. Cardiovasc Ultrasound 19:10. https://doi.org/10.1186/1476-7120-10-10. ; Kuznetsova T, Herbots L, López B, Jin Y, Richart T, Thijs L, González A, Herregods MC, Fagard RH, Díez J, Staessen JA (2009) Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2:105–112. https://doi.org/10.1161/CIRCHEARTFAILURE.108.822627. ; Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, Guillevin L, Kahan A, Allanore Y (2008) Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum 58:1803–1809. https://doi.org/10.1002/art.23463. ; Ciurzyński M, Bienias P, Irzyk K, Kostrubiec M, Bartoszewicz Z, Siwicka M, Kurzyna M, Demkow U, Pruszczyk P (2013) Exaggerated increase of exercise-induced pulmonary artery pressure in systemic sclerosis patients predominantly results from left ventricular diastolic dysfunction. Clin Res Cardiol 102:813–820. https://doi.org/10.1007/s00392-013-0594-x. ; Tennøe AH, Murbræch K, Andreassen JC, Fretheim H, Garen T, Gude E, Andreassen A, Aakhus S, Molberg Ø, Hoffmann-Vold AM (2018) Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis. J Am Coll Cardiol 72:1804–1813. https://doi.org/10.1016/j.jacc.2018.07.068. ; Desai CS, Colangelo LA, Liu K, Jacobs DR Jr, Cook NL, Lloyd-Jones DM, Ogunyankin KO (2013) Prevalence, prospective risk markers, and prognosis associated with the presence of left ventricular diastolic dysfunction in young adults: the coronary artery risk development in young adults study. Am J Epidemiol 177:20–32. https://doi.org/10.1093/aje/kws224. ; Hajdu MA, Heistad DD, Siems JE, Baumbach GL (1990) Effects of aging on mechanics and composition of cerebral arterioles in rats. Circ Res 66:1747–1754. https://doi.org/10.1161/01.res.66.6.1747. ; Dai DF, Chen T, Johnson SC, Szeto H, Rabinovitch PS (2011) Cardiac aging: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal 16:1492–1526. https://doi.org/10.1089/ars.2011.4179. ; Carreira PE, Carmona L, Joven BE, Loza E, Andréu JL, Riemekasten G, Vettori S, Balbir-Gurman A, Airò P, Walker U, Damjanov N, Matucci-Cerinic M, Ananieva LP, Rednic S, Czirják L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Allanore Y (2019) Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database. Scand J Rheumatol 48:42–51. https://doi.org/10.1080/03009742.2018.1459830. ; Jaeger VK, Wirz EG, Allanore Y, Rossbach P, Riemekasten G, Hachulla E, Distler O, Airò P, Carreira PE, Balbir Gurman A, Tikly M, Vettori S, Damjanov N, Müller-Ladner U, Distler JH, Li M, Walker UA; EUSTAR co-authors (2016) Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study. PLoS One 11:e0163894. https://doi.org/10.1371/journal.pone.0163894. ; Tonelli AR, Plana JC, Heresi GA, Dweik RA (2012) Prevalence and prognostic value of left ventricular diastolic dysfunction in idiopathic and heritable pulmonary arterial hypertension. Chest 141:1457–1465. https://doi.org/10.1378/chest.11-1903. ; Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, Sulli A, Piette Y, De Keyser F, Cutolo M (2013) Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol 40:2023–2028. https://doi.org/10.3899/jrheum.130528. ; Repa A, Avgoustidis N, Kougkas N, Bertsias G, Zafiriou M, Sidiropoulos P (2019) Nailfold videocapillaroscopy as a candidate biomarker for organ involvement and prognosis in patients with systemic sclerosis. Mediterr J Rheumatol 30:48–50. https://doi.org/10.31138/mjr.30.1.48. ; Jia G, Habibi J, Bostick BP, Ma L, DeMarco VG, Aroor AR, Hayden MR, Whaley-Connell AT, Sowers JR (2015) Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet. Hypertension 65:531–539. https://doi.org/10.1161/HYPERTENSIONAHA.114.04737. ; Georgiopoulos G, Tsioufis C, Kalos T, Magkas N, Roussos D, Chrysohoou C, Sarri G, Syrmali K, Georgakopoulos P, Tousoulis D (2019) Serum uric acid is independently associated with diastolic dysfunction in apparently healthy subjects with essential hypertension. Curr Vasc Pharmacol 17:99–106. https://doi.org/10.2174/1570161116666171226124959. ; Lee HJ, Kim HL, Lim WH, Seo JB, Kim SH, Zo JH, Kim MA (2019) Subclinical alterations in left ventricular structure and function according to obesity and metabolic health status. PLoS One 14:e0222118. https://doi.org/10.1371/journal.pone.0222118. ; Widya RL, de Mutsert R, den Heijer M, le Cessie S, Rosendaal FR, Jukema JW, Smit JW, de Roos A, Lamb HJ; NEO Study Group (2016) Association between hepatic triglyceride content and left ventricular diastolic function in a population-based cohort: the Netherlands epidemiology of obesity study. Radiology 279:443–450. https://doi.org/10.1148/radiol.2015150035. ; Ayalon N, Gopal DM, Mooney DM, Simonetti JS, Grossman JR, Dwivedi A, Donohue C, Perez AJ, Downing J, Gokce N, Miller EJ, Liang CS, Apovian CM, Colucci WS, Ho JE (2014) Preclinical left ventricular diastolic dysfunction in metabolic syndrome. Am J Cardiol 114:838–842. https://doi.org/10.1016/j.amjcard.2014.06.013. ; McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developedin collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847. https://doi.org/10.1093/eurheartj/ehs104.
- Grant Information: 2019-I2M-2-008 CAMS Innovation Fund for Medical Sciences (CIFMS)
- Contributed Indexing: Keywords: Cardiovascular disease; Cohort study; Prevalence; Risk factors; Systemic sclerosis
- Entry Date(s): Date Created: 20210618 Date Completed: 20211019 Latest Revision: 20211019
- Update Code: 20231215
|
